By Modupe Gbadeyanka
One of Nigeria’s largest pharmaceutical manufacturing companies, Evans Medical Plc, has lost its assets to its bankers.
In a statement issued last week, the firm, established in 1954, explained that it lost its assets after it failed to meet up with the loans it took from Skye Bank and First Bank.
As a result of this development, the two banks obtained a court order to take over the company’s assets.
However, the pharmaceutical manufacturing company did not state the exact amount of loan it took from the lenders.
“Evans Medical Plc (Evans Medical) would like to announce that the company’s bankers (Skye Bank PLC and First Bank of Nigeria Limited) have served the company with an ex-parte order of the Federal High Court dated July 4, 2017, granting them the right to take over the company’s assets used as collateral against facilities granted to the company by the bankers due to loan default.
“A Receiver Manager has also been appointed and has taken over the assets of the company,” the statement said.
Speaking further, the firm said its board has commenced talks with the two financial institutions on how to resolve the issue amicably.
“The board of Evans Medical however has begun discussions with the two lenders with a view to arriving at an amicable resolution of the matter and the discussions are progressing favourably and we are optimistic that a mutually beneficial workable arrangement will be arrived at between the banks and our board as soon as possible in order to safeguard the company’s properties and assets as well as protect the shareholders’ investments,” the statement said.
Concluding, the company has promised to keep its shareholders “informed accordingly and we appreciate your understanding in this matter.”
Recall that some months ago, a consortium of Nigerian bank had attempted to take over Etisalat Nigeria, now 9mobile, after the telecom firm failed to meet up with repayment plan of the $1.2 billion loan it took.
However, the takeover move was botched by the Central Bank of Nigeria (CBN) so as not to send wrong signals to foreign investors.
more recommended stories
mPharma Gets Fresh $17m to Conquer Africa
By Adedapo Adesanya Leading Ghanaian healthtech.
Cases of Coronavirus in Nigeria Jump to 8,068
By Dipo Olowookere The Nigeria Centre.
Stakeholders Await Use of Interswitch’s Software on COVID-19
By Modupe Gbadeyanka Some stakeholders in.
World Hypertension Day: LASUTH Cardiologists Advocates Regular BP Check Despite COVID-19
By Modupe Gbadeyanka Cardiologists at the.
COVID-19: Urgent Need for African Governments to Upgrade Health Systems
By Kester Kenn Klomegah Amid multifold.
More Woes for Evans Medical, to Pay N71m in 30 Days
By Modupe Gbadeyanka It is not.
CBN to Fund Research for COVID-19 Vaccine
By Adedapo Adesanya The Central Bank.
Salako Heads National Health Research Committee
By Modupe Gbadeyanka The Director General.